Invesco
NMRA icon

Invesco’s Neumora Therapeutics NMRA Stock Holding History

Invesco’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$402K Sell
205,929
-21,665
-10% -$56.1K ﹤0.01% 3242
2025
Q4 		$407K Buy
227,594
+43,795
+24% +$95.9K ﹤0.01% 3279
2025
Q3 		$335K Buy
183,799
+51,761
+39% +$83.7K ﹤0.01% 3379
2025
Q2 		$96.8K Buy
132,038
+8,383
+7% +$6.35K ﹤0.01% 3657
2025
Q1 		$124K Buy
123,655
+74,406
+151% +$127K ﹤0.01% 3600
2024
Q4 		$522K Buy
49,249
+35,342
+254% +$424K ﹤0.01% 3221
2024
Q3 		$184K Buy
13,907
+462
+3% +$5.39K ﹤0.01% 3532
2024
Q2 		$132K Buy
+13,445
New +$139K ﹤0.01% 3716

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return